DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 3Dr. Reddy's Laboratories
02 2ADAPTIS
03 2American Regent
04 2Amneal Pharmaceuticals
05 2Amphastar Pharmaceuticals
06 2Amring Pharma
07 4Aurobindo Pharma Limited
08 2Avet Pharmaceuticals
09 1B. Braun Medical
10 4Biological E
11 2Caplin Point Laboratories Limited
12 1EQL Pharma
13 3Exela Pharma Sciences, LLC.
14 8Farbe Firma
15 3Fresenius Kabi USA
16 2Fresenius SE & Co. KGaA
17 2GLAND PHARMA LIMITED
18 1Grindeks AS
19 1Hanlim Pharmaceuticals Inc
20 3Hikma Pharmaceuticals
21 1JAMP PHARMA
22 1Labiana Life Sciences S.A
23 1Lifespan Biotech
24 2MARCAN PHARMACEUTICALS INC
25 2Meitheal Pharmaceuticals
26 2Montage Laboratories
27 1ORIFARM GROUP AS
28 3Omega Laboratories Limited
29 2PH HEALTH
30 2Pharmascience Inc.
31 2Pluviaendo
32 1Polifarma
33 1SINTETICA SA
34 2Sagent Pharmaceuticals
35 3Themis Medicare
36 2Umedica Laboratories
37 1Unimedic Pharma Ab
38 3Viatris
39 1Winston Medical Supply
40 1Zhejiang Xianju Pharmaceutical Co. Ltd
Reset all filters
01 2Ampoule
02 1EYE DROP
03 1Eye Drops
04 2INJ
05 2INJECTABLE;INJECTION
06 1INJECTION
07 5Injectable Solution
08 13Injection
09 1Injection Solution
10 4LIQUID
11 2Liquid Injection
12 4SOLUTION
13 40SOLUTION;INTRAVENOUS
14 3Solution For Injection
15 2Vial
16 1Blank
Reset all filters
01 3Allowed
02 3Approved
03 1Authorized
04 4DISCN
05 1Deregistered
06 3Generic
07 1Generic eCTD
08 8Prescription
09 36RX
10 24Blank
Reset all filters
01 3BLOXIVERZ
02 1Copneg
03 1EYEFEEL
04 39NEOSTIGMINE METHYLSULFATE
05 2NEOSTIGMINE METHYLSULFATE INJECTION USP
06 1NEOSTIGMINE METHYLSULFATE INJECTION, USP
07 3NEOSTIGMINE OMEGA
08 1Neostigmina Brown
09 1Neostigmine
10 2Neostigmine Methylsulphate
11 1Neostigmine Methylsulphate Fresenius 0.5Mg/Ml
12 1Neostigmine Methylsulphate Fresenius 2.5Mg/1Ml (Ampoules)
13 1Neotagmin 1
14 1Neotagmin 5
15 1Neotagmin P
16 1PMS-NEOSTIGMINE METHYLSULFATE INJ 0.5MG/ML
17 1PMS-NEOSTIGMINE METHYLSULFATE INJ 1MG/ML
18 2Prostigmin
19 3Robinul-Neostigmine
20 1Rumintral
21 1Shushiming
22 16Blank
Reset all filters
01 8Canada
02 1China
03 16India
04 1Latvia
05 2South Africa
06 1South Korea
07 1Spain
08 4Sweden
09 3Switzerland
10 1Taiwan
11 3Turkey
12 42USA
13 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2018-07-10
Application Number : 209135
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/10ML (1MG/ML)
Packaging :
Approval Date : 2018-07-10
Application Number : 209135
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 3MG/3ML (1MG/ML)
Packaging :
Approval Date : 2022-07-06
Application Number : 216291
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2018-05-04
Application Number : 209182
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/10ML (1MG/ML)
Packaging :
Approval Date : 2018-05-04
Application Number : 209182
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2018-06-15
Application Number : 210051
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2017-09-25
Application Number : 209933
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/10ML (1MG/ML)
Packaging :
Approval Date : 2017-09-25
Application Number : 209933
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2022-11-25
Application Number : 208230
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/10ML (1MG/ML)
Packaging :
Approval Date : 2022-11-25
Application Number : 208230
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BLOXIVERZ
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2013-05-31
Application Number : 204078
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BLOXIVERZ
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/10ML (1MG/ML)
Packaging :
Approval Date : 2013-05-31
Application Number : 204078
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BLOXIVERZ
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/5ML (1MG/ML)
Packaging :
Approval Date : 2023-10-27
Application Number : 204078
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2015-01-08
Application Number : 203629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/10ML (1MG/ML)
Packaging :
Approval Date : 2015-01-08
Application Number : 203629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 3MG/3ML (1MG/ML)
Packaging :
Approval Date : 2018-09-18
Application Number : 203629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2015-12-28
Application Number : 207042
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/10ML (1MG/ML)
Packaging :
Approval Date : 2015-12-28
Application Number : 207042
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 5MG/10ML (0.5MG/ML)
Packaging :
Approval Date : 2017-04-26
Application Number : 208405
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : RX
Registration Country : USA
Brand Name : NEOSTIGMINE METHYLSULFATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 10MG/10ML (1MG/ML)
Packaging :
Approval Date : 2017-04-26
Application Number : 208405
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF